Cargando…
Role of short-acting nitroglycerin in the management of ischemic heart disease
Nitroglycerin is the oldest and most commonly prescribed short-acting anti-anginal agent; however, despite its long history of therapeutic usage, patient and health care provider education regarding the clinical benefits of the short-acting formulations in patients with angina remains under-apprecia...
Autores principales: | Boden, William E, Padala, Santosh K, Cabral, Katherine P, Buschmann, Ivo R, Sidhu, Mandeep S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548722/ https://www.ncbi.nlm.nih.gov/pubmed/26316714 http://dx.doi.org/10.2147/DDDT.S79116 |
Ejemplares similares
-
Nitroglycerin application and coronary arteriogenesis
por: Gatzke, Nora, et al.
Publicado: (2018) -
Nitroglycerine
Publicado: (1895) -
Vericiguat in Combination with Short‐Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study
por: Boettcher, Michael, et al.
Publicado: (2022) -
Topical nitroglycerin in newborns with ischemic injuries: A systematic review
por: Mosalli, Rafat, et al.
Publicado: (2021) -
The Dose of Nitroglycerine
Publicado: (1892)